Pfizer Inc. (NYSE:PFE) is one of the best low volatility large cap stocks to invest in. On November 24, Guggenheim lifted the price target on Pfizer Inc. (NYSE:PFE) to $35 from $33 while keeping a Buy ...
Pfizer stock (NYSE: PFE) is currently in a significant slump, marking its ninth consecutive day of decline and losing a total of −11% of its value over that period. This sustained sell-off has wiped ...
Pfizer (PFE) has seen its stock fall to its lowest level in 13 years as pressure from falling blockbuster drug sales weighs on performance. CEO Bourla maintains supporting the dividend is a high ...
We recently published a list of Jim Cramer’s Thoughts on These 5 Stocks. In this article, we are going to take a look at where Pfizer Inc. (NYSE:PFE) stands against other stocks that Jim Cramer ...
Pfizer stock (NYSE: PFE) recently reported its Q4 results, with revenues and earnings exceeding the street estimates. The company reported revenue of $17.8 billion and adjusted earnings of $0.63 per ...
Today, I’m upgrading my rating for PFE due to several positive trends, both within the company and driven by broader market factors. The stock price dropped after the Q2 earnings release despite ...
Zacks Investment Research on MSN
Pfizer (PFE) outpaces stock market gains: What you should know
In the latest close session, Pfizer (PFE) was up +1.12% at $25.18. The stock outpaced the S&P 500's daily gain of 0.19%. Meanwhile, the Dow experienced a rise of 0.66%, and the technology-dominated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback